Literature DB >> 26489873

Epitope specific T-cell responses against influenza A in a healthy population.

Miloje Savic1,2, Jennifer L Dembinski1,2, Yohan Kim3, Gro Tunheim1,2, Rebecca J Cox2,4, Fredrik Oftung1,2, Bjoern Peters3, Siri Mjaaland1,2.   

Abstract

Pre-existing human CD4(+) and CD8(+) T-cell-mediated immunity may be a useful correlate of protection against severe influenza disease. Identification and evaluation of common epitopes recognized by T cells with broad cross-reactivity is therefore important to guide universal influenza vaccine development, and to monitor immunological preparedness against pandemics. We have retrieved an optimal combination of MHC class I and class II restricted epitopes from the Immune Epitope Database (www.iedb.org), by defining a fitness score function depending on prevalence, sequence conservancy and HLA super-type coverage. Optimized libraries of CD4(+) and CD8(+) T-cell epitopes were selected from influenza antigens commonly present in seasonal and pandemic influenza strains from 1934 to 2009. These epitope pools were used to characterize human T-cell responses in healthy donors using interferon-γ ELISPOT assays. Upon stimulation, significant CD4(+) and CD8(+) T-cell responses were induced, primarily recognizing epitopes from the conserved viral core proteins. Furthermore, the CD4(+) and CD8(+) T cells were phenotypically characterized regarding functionality, cytotoxic potential and memory phenotype using flow cytometry. Optimized sets of T-cell peptide epitopes may be a useful tool to monitor the efficacy of clinical trials, the immune status of a population to predict immunological preparedness against pandemics, as well as being candidates for universal influenza vaccines.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell epitopes; biomarkers; cross-reactivity; influenza A virus; vaccine

Mesh:

Substances:

Year:  2015        PMID: 26489873      PMCID: PMC4717245          DOI: 10.1111/imm.12548

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  69 in total

1.  Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.

Authors:  Steven Black; Uwe Nicolay; Timo Vesikari; Markus Knuf; Giuseppe Del Giudice; Giovanni Della Cioppa; Theodore Tsai; Ralf Clemens; Rino Rappuoli
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes.

Authors:  Evan W Newell; Natalia Sigal; Sean C Bendall; Garry P Nolan; Mark M Davis
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

3.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

4.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

5.  The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming.

Authors:  Stephen M Todryk; Ansar A Pathan; Sheila Keating; David W Porter; Tamara Berthoud; Fiona Thompson; Paul Klenerman; Adrian V S Hill
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

6.  Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.

Authors:  Marine L B Hillaire; Stella E van Trierum; Joost H C M Kreijtz; Rogier Bodewes; Martina M Geelhoed-Mieras; Nella J Nieuwkoop; Ron A M Fouchier; Thijs Kuiken; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Gen Virol       Date:  2011-06-08       Impact factor: 3.891

7.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

Review 8.  Avian influenza A (H5N1) age distribution in humans.

Authors:  Matthew Smallman-Raynor; Andrew D Cliff
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

9.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

10.  Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Authors:  Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more
  21 in total

1.  Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Katherine Richards; Frances Batarse; Laura Lockard; Hui Zeng; Adolfo García-Sastre; Randy A Albrecht; Andrea J Sant
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

2.  Heterologous viral protein interactions within licensed seasonal influenza virus vaccines.

Authors:  Marina Koroleva; Frances Batarse; Savannah Moritzky; Carole Henry; Francisco Chaves; Patrick Wilson; Florian Krammer; Katherine Richards; Andrea J Sant
Journal:  NPJ Vaccines       Date:  2020-01-10       Impact factor: 7.344

Review 3.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 4.  Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.

Authors:  Andrea J Sant; Katherine A Richards; Jennifer Nayak
Journal:  Curr Opin Immunol       Date:  2018-04-02       Impact factor: 7.486

5.  Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.

Authors:  Ajitanuj Rattan; Katherine A Richards; Zackery A G Knowlden; Andrea J Sant
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

6.  Highly conserved influenza T cell epitopes induce broadly protective immunity.

Authors:  Christopher S Eickhoff; Frances E Terry; Linda Peng; Krystal A Meza; Isaac G Sakala; Daniel Van Aartsen; Leonard Moise; William D Martin; Jill Schriewer; R Mark Buller; Anne S De Groot; Daniel F Hoft
Journal:  Vaccine       Date:  2019-07-19       Impact factor: 3.641

7.  High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia.

Authors:  Jennifer L Dembinski; Adane Mihret; Solomon A Yimer; Bamlak Tessema; Mai-Chi Trieu; Azeb Tarekegn; Nahom Getachew; Rebecca J Cox; Fredrik Oftung; Bjørn Haneberg; Abraham Aseffa; Siri Mjaaland
Journal:  Open Forum Infect Dis       Date:  2017-02-11       Impact factor: 3.835

Review 8.  Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Authors:  Elena Muraro; Anna Merlo; Debora Martorelli; Michela Cangemi; Silvia Dalla Santa; Riccardo Dolcetti; Antonio Rosato
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 9.  The CD8 T Cell Response to Respiratory Virus Infections.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

10.  Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Authors:  Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.